Back to results

Elemental Impurities – Parenteral Dosage Form Case Study – Approach and Challenges

by J. Mason of Merck & Co., Inc., shared as part of the PQRI/USP Elemental Impurities Workshop (November 2016) on the PQRI website
Potential sources of impurity risks in a parenteral drug product: equipment, water, gases, excipients, drug substances and container closure systems.

Please Signup/Login to see the full article.